Subscribe To
Leading independent proxy advisory firm iss recommends paratek pharmaceuticals stockholders vote for the acquisition by gurnet point capital and novo holdings
BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (“Paratek”) (Nasdaq: PRTK), a commercial-stage biopharmaceutical company...
September 7, 2023, 7:34 pm
Lifshitz law pllc announces investigations of prtk, cir, reun, and fate
NEW YORK, June 10, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) Lifshitz Law PLLC announces an investigation into possible b...
June 11, 2023, 12:11 am
Paratek pharmaceuticals to be acquired by gurnet point capital and novo holdings
Transaction Provides Paratek Shareholders with Immediate Value and Liquidity Reflects Potential Value of $3.00 per Share of Common Stock, Including Up...
June 6, 2023, 1:05 pm